Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.
Journal: Cancer immunology, immunotherapy : CII
Published: May 15, 2016
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma.
Journal: Molecular cancer therapeutics
Published: October 17, 2014
Showing 1-3 of 3
Last Updated: 09/26/2026